|
Lurbinectedin Clinical Trials
13 actively recruiting trials across 9 locations
Also known as: JZP712, PM01183, Zepzelca
Other2 trials
Los Angeles, California2 trials
Lurbinectedin in FET-Fused Tumors
Cedars-Sinai Medical Center
Phase 1/2
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Children's Hospital of Los Angeles
Phase 1/2
Bethesda, Maryland2 trials
Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers
National Institutes of Health Clinical Center
Phase 1/2
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
National Institutes of Health Clinical Center
Phase 2
Phoenix, Arizona1 trial
Springdale, Arkansas1 trial
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Highlands Oncology Group
Phase 3
Ocala, Florida1 trial
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Ocala Oncology Center /ID# 278269
Phase 2
Atlanta, Georgia1 trial
Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
Emory University Hospital Midtown
Phase 1
Lebanon, New Hampshire1 trial
Study of Trilaciclib and Lurbinectidin
Dartmouth Hitchcock Medical Center
Phase 2
Philadelphia, Pennsylvania1 trial
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
Fox Chase Cancer Center
Phase 2
Houston, Texas1 trial
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
M D Anderson Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.